Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Allarity Therapeutics

Clinical trials sponsored by Allarity Therapeutics, explained in plain language.

Allarity Therapeutics ALLR NASDAQ

Develops personalized cancer therapies using drug response prediction.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Terminated 2

New test could match ovarian cancer patients to the right drug

Knowledge-focused Recruiting now

This study is testing a device called a Drug Response Predictor (DRP) that uses a sample of a patient's tumor to see if it will respond to certain cancer drugs. The trial involves 60 people with advanced ovarian cancer that has stopped responding to platinum chemotherapy. The goa…

Sponsor: Allarity Therapeutics • Aim: Knowledge-focused

Last updated Aug 01, 2026 00:00 UTC